Literature DB >> 15840561

Is prostate-specific membrane antigen a multifunctional protein?

Ayyappan K Rajasekaran1, Gopalakrishnapillai Anilkumar, Jason J Christiansen.   

Abstract

Prostate-specific membrane antigen (PSMA) is a metallopeptidase expressed predominantly in prostate cancer (PCa) cells. PSMA is considered a biomarker for PCa and is under intense investigation for use as an imaging and therapeutic target. Although the clinical utility of PSMA in the detection and treatment of PCa is evident and is being pursued, very little is known about its basic biological function in PCa cells. The purpose of this review is to highlight the possibility that PSMA might be a multifunctional protein. We suggest that PSMA may function as a receptor internalizing a putative ligand, an enzyme playing a role in nutrient uptake, and a peptidase involved in signal transduction in prostate epithelial cells. Insights into the possible functions of PSMA should improve the diagnostic and therapeutic values of this clinically important molecule.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15840561     DOI: 10.1152/ajpcell.00506.2004

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  67 in total

1.  Immunocapture of prostate cancer cells by use of anti-PSMA antibodies in microdevices.

Authors:  Steven M Santana; He Liu; Neil H Bander; Jason P Gleghorn; Brian J Kirby
Journal:  Biomed Microdevices       Date:  2012-04       Impact factor: 2.838

2.  2-(3-{1-Carboxy-5-[(6-[18F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid, [18F]DCFPyL, a PSMA-based PET imaging agent for prostate cancer.

Authors:  Ying Chen; Mrudula Pullambhatla; Catherine A Foss; Youngjoo Byun; Sridhar Nimmagadda; Srinivasan Senthamizhchelvan; George Sgouros; Ronnie C Mease; Martin G Pomper
Journal:  Clin Cancer Res       Date:  2011-10-31       Impact factor: 12.531

3.  [(18)F]Fluorobenzoyllysinepentanedioic Acid Carbamates: New Scaffolds for Positron Emission Tomography (PET) Imaging of Prostate-Specific Membrane Antigen (PSMA).

Authors:  Xing Yang; Ronnie C Mease; Mrudula Pullambhatla; Ala Lisok; Ying Chen; Catherine A Foss; Yuchuan Wang; Hassan Shallal; Hannah Edelman; Adam T Hoye; Giorgio Attardo; Sridhar Nimmagadda; Martin G Pomper
Journal:  J Med Chem       Date:  2015-12-16       Impact factor: 7.446

Review 4.  Prostate immunotherapy: should all guns be aimed at the prostate-specific antigen?

Authors:  Dev Karan
Journal:  Immunotherapy       Date:  2013-09       Impact factor: 4.196

Review 5.  Insight into nanoparticle cellular uptake and intracellular targeting.

Authors:  Basit Yameen; Won Il Choi; Cristian Vilos; Archana Swami; Jinjun Shi; Omid C Farokhzad
Journal:  J Control Release       Date:  2014-06-28       Impact factor: 9.776

6.  Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.

Authors:  Rajendra Prasad Bandari; Zongrun Jiang; Tamila Stott Reynolds; Nicole E Bernskoetter; Ashley F Szczodroski; Kurt J Bassuner; Daniel L Kirkpatrick; Tammy L Rold; Gary L Sieckman; Timothy J Hoffman; James P Connors; Charles J Smith
Journal:  Nucl Med Biol       Date:  2014-01-10       Impact factor: 2.408

Review 7.  Update on current and potential nanoparticle cancer therapies.

Authors:  Jonathan S Rink; Michael P Plebanek; Sushant Tripathy; C Shad Thaxton
Journal:  Curr Opin Oncol       Date:  2013-11       Impact factor: 3.645

8.  The proinflammatory cytokine, IL-6, and its interference with bFGF signaling and PSMA in prostate cancer cells.

Authors:  Awatef Ben Jemaa; Sataa Sallami; Dunia Ramarli; Marco Colombatti; Ridha Oueslati
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

9.  Nuclear versus cytoplasmic localization of filamin A in prostate cancer: immunohistochemical correlation with metastases.

Authors:  Roble G Bedolla; Yu Wang; Alfredo Asuncion; Karim Chamie; Salma Siddiqui; Maria M Mudryj; Thomas J Prihoda; Javed Siddiqui; Arul M Chinnaiyan; Rohit Mehra; Ralph W de Vere White; Paramita M Ghosh
Journal:  Clin Cancer Res       Date:  2009-02-01       Impact factor: 12.531

10.  Preparation and affinity identification of glutamic acid-urea small molecule analogs in prostate cancer.

Authors:  Zhiwei Zhang; Zheng Zhu; Deyong Yang; Weiwei Fan; Jianbo Wang; Xiancheng Li; Xiaochi Chen; Qifeng Wang; Xishuang Song
Journal:  Oncol Lett       Date:  2016-06-10       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.